|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.00 NOK | +0.96% |
|
-0.57% | +6.38% |
| Apr. 15 | Carnegie High Yield slips 0.43 percent in March - maintains defensive stance | FW |
| Mar. 26 | Aker BioMarine ASA Announces Stepping Down of Board Members | CI |
Company Valuation: Aker BioMarine ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 4,756 | 3,335 | 4,033 | 5,884 | 8,656 | 9,209 | - | - |
| Change | - | -29.89% | 20.94% | 45.89% | 47.12% | 6.38% | - | - |
| Enterprise Value (EV) 1 | 7,551 | 7,194 | 7,904 | 7,520 | 10,153 | 10,428 | 10,209 | 9,296 |
| Change | - | -4.73% | 9.86% | -4.86% | 35.02% | 2.7% | -2.1% | -8.94% |
| P/E ratio | -61.6x | 35.1x | -41.2x | 2.85x | -37.8x | 45.1x | 25.1x | 15.2x |
| PBR | 1.44x | 0.89x | 1.08x | 2.98x | 5.99x | 5.96x | 4.47x | 3.55x |
| PEG | - | -0x | 0x | -0x | 0x | -0x | 0.3x | 0.2x |
| Capitalization / Revenue | 2.04x | 1.18x | 1.13x | 1.92x | 4.18x | 4.04x | 3.27x | 3.26x |
| EV / Revenue | 3.25x | 2.55x | 2.21x | 2.45x | 4.91x | 4.57x | 3.62x | 3.29x |
| EV / EBITDA | 17.7x | 10.3x | 10.6x | 11.2x | 23.4x | 18.9x | 13.2x | 10.3x |
| EV / EBIT | -62.7x | 32x | 140x | 249x | 83.6x | 30.8x | 19.1x | 13.5x |
| EV / FCF | -11.1x | -27.2x | 497x | -61.1x | -626x | 41.2x | 20.2x | 14.8x |
| FCF Yield | -8.98% | -3.68% | 0.2% | -1.64% | -0.16% | 2.43% | 4.96% | 6.76% |
| Dividend per Share 3 | - | - | - | 4.302 | - | - | - | - |
| Rate of return | - | - | - | 72.9% | - | - | - | - |
| EPS 3 | -0.1 | 0.11 | -0.11 | 2.07 | -0.26 | 0.25 | 0.4483 | 0.74 |
| Distribution rate | - | - | - | 208% | - | - | - | - |
| Net sales 1 | 2,327 | 2,817 | 3,572 | 3,064 | 2,069 | 2,280 | 2,819 | 2,824 |
| EBITDA 1 | 426.4 | 701.1 | 745.8 | 672 | 434.4 | 552.1 | 776 | 901.8 |
| EBIT 1 | -120.5 | 224.6 | 56.47 | 30.24 | 121.4 | 338.4 | 535.7 | 688.1 |
| Net income 1 | -76.96 | 101.6 | -95.89 | 2,033 | -216.2 | 202.5 | 378.8 | 608.4 |
| Net Debt 1 | 2,795 | 3,859 | 3,871 | 1,636 | 1,497 | 1,219 | 999.7 | 87.18 |
| Reference price 3 | 6.16 | 3.86 | 4.54 | 5.90 | 9.83 | 11.27 | 11.27 | 11.27 |
| Nbr of stocks (in thousands) | 87,586 | 87,638 | 87,673 | 87,685 | 87,703 | 87,703 | - | - |
| Announcement Date | 2/17/22 | 2/15/23 | 2/14/24 | 2/12/25 | 2/12/26 | - | - | - |
1USD in Million2NOK in Million3USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 41.06x | 4.37x | 17.56x | -.--% | 972M | |
| 15.87x | 1.17x | 9.59x | 1.88% | 16.43B | |
| 8.68x | 1.09x | 8.93x | 4.86% | 5.16B | |
| 12.72x | 1.39x | 6.54x | 2.01% | 2.83B | |
| 13.55x | - | - | - | 2B | |
| 7.61x | 0.53x | 4.81x | 5.39% | 1.85B | |
| 8.94x | 1.97x | 6.24x | 5.37% | 1.77B | |
| 9.36x | - | - | - | 1.69B | |
| 42.61x | 0.76x | 8.01x | 1.35% | 1.61B | |
| Average | 17.82x | 1.61x | 8.81x | 2.98% | 3.81B | |
| Weighted average by Cap. | 15.24x | 1.26x | 8.88x | 2.72% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- AKBM Stock
- Valuation Aker BioMarine ASA
Select your edition
All financial news and data tailored to specific country editions
